← ASCENTAGE PHARMA GROUP INTERNATIONAL
| Annual Trend | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $54k |
$15
-99.97%
|
$0
-100.00%
|
$0 | $0 | — | $209.7m |
$222.0m
+5.85%
|
$142.2m
-35.94%
|
$574.1m
+303.72%
|
$574.1m
0.00%
|
|
| Cost of Goods and Services Sold | $38k |
$2
-99.99%
|
— | — | — | — | ($22.0m) |
$30.5m
+238.84%
|
$4.0m
-86.96%
|
($48.9m)
-1328.36%
|
$48.9m
+200.00%
|
|
| Cost Of Revenue | — | $23k | — | — | — | — | $22.0m |
$30.5m
+38.84%
|
$29.1m
-4.77%
|
$48.9m
+68.26%
|
$48.9m
0.00%
|
|
| Total cost of sales | — | — | — | — | — | — | ($22.0m) |
($30.5m)
-38.84%
|
($29.1m)
+4.77%
|
($48.9m)
-68.26%
|
— | |
| Net Interest Income | — | — | — | — | — | — | ($43.1m) |
($63.6m)
-47.82%
|
($26.6m)
+58.18%
|
$28.1m
+205.41%
|
$28.1m
0.00%
|
|
| Gross Profit | $16k |
$13
-99.92%
|
— | — | — | — | $187.7m |
$191.4m
+1.99%
|
$130.4m
-31.90%
|
$525.2m
+302.86%
|
$525.2m
0.00%
|
|
| Research and development | — | — | — | — | — | — | $743.1m | $707.0m | $129.8m | $1.1b | $1.1b | |
| Selling, General and Administrative Expense | — | $10k | $5 | $8k | $29k | — | $170.6m | $181.1m | $187.1m | $246.3m | $599.9m | |
| Operating expenses: | ||||||||||||
| Other Operating Expenses | — | — | — | — | — | — | ($33.6m) | ($19.4m) | ($9.1m) | ($14.5m) | — | |
| Total Operating Expenses | $114k | $140k | $163k | $0 | $348k | — | — | — | — | — | $1.8b | |
| EBIT | ($834.4m) | ($836.8m) | ($330.8m) | ($1.2b) | ($1.2b) | |||||||
| Loss from operations | ($98k) | — | — | ($254k) |
($833k)
-227.40%
|
— | — | — | — | — | — | |
| Other Non Operating Income Expenses | — | — | — | — | — | — | ($3.1m) | ($1.4m) | ($4.4m) | ($55.4m) | — | |
| Interest Expense On Lease Liabilities | — | — | — | — | — | — | — | $1.3m | $205k | — | $54.1m | |
| Interest expense | $2k | ($11k) | ($20k) | ($28k) | ($23k) | — | $52.8m | $96.1m | $64.5m | $54.1m | $54.1m | |
| Interest Income | — | — | — | — | — | — | $9.7m | $32.4m | $37.8m | $82.1m | $82.1m | |
| Net Non Operating Interest Income Expense | — | — | — | — | — | — | ($43.1m) | ($63.6m) | ($26.6m) | $28.1m | $28.1m | |
| Gain On Sale Of PPE | — | — | — | — | — | — | $2.1m | $4k | ($50k) | ($18k) | ($18k) | |
| Gain On Sale Of Security | — | — | — | — | — | — | $7.0m | $3.7m | $5.9m | ($11.3m) | ($11.3m) | |
| Other Income | — | — | — | — | — | — | — | $59.3m | $7.9m | — | — | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | — | — | — | — | — | — | ($3) | ($38k) | ($38k) | ($3) | — | |
| Other income and gains | — | — | — | — | — | — | $67.0m | $59.3m | $57.4m | $103.5m | — | |
| Other expenses | — | — | — | — | — | — | ($17.7m) | ($5.2m) | ($9.1m) | ($73.6m) | — | |
| Non-Operating Income (Expense) | — | $13k | — | $0 | ($155k) | — | — | — | — | — | — | |
| Other Income Expense | — | — | — | — | — | — | $5.7m | $3.4m | $1.1m | ($66.4m) | ($66.4m) | |
| Net loss before income taxes | — | ($155k) | ($782k) | — | — | — | — | — | — | — | — | |
| Income Before Tax | — | ($144k) | ($762k) | — | — | — | — | — | — | — | ($1.2b) | |
| Pre-Tax Income | — | — | — | — | — | — | ($887.2m) | ($932.9m) | ($395.3m) | ($1.2b) | ($1.2b) | |
| Deferred Tax Expense (Income) | — | — | $0 | $0 | — | — | — | ($7.2m) | $1.4m | — | — | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | — | — | $0 | $0 | — | — | — | ($1.5m) | ($3.9m) | — | — | |
| Income Tax Expense Continuing Operations | — | — | $163k | $254k | — | — | — | ($7.2m) | $1.4m | — | $6.9m | |
| Income tax credit/(expense) | — | — | — | — | — | — | $4.2m | $7.2m | ($10.4m) | ($6.9m) | — | |
| Income Tax Expense | — | — | $0 | $0 | — | — | — | — | — | — | $6.9m | |
| Net Income From Continuing And Discontinued Operation | — | ($155k) | ($782k) | ($283k) | ($1.5m) | — | ($882.9m) | ($925.6m) | ($405.4m) | ($1.2b) | ($1.2b) | |
| Net Income Continuous Operations | — | ($155k) | ($782k) | ($283k) | ($1.5m) | — | ($882.9m) | ($925.7m) | ($405.7m) | ($1.2b) | ($1.2b) | |
| Otherunder Preferred Stock Dividend | — | — | — | — | — | $0 | $0 | $0 | — | — | — | |
| Basic Earnings (Loss) Per Share | $-0.00 | $-0.00 | ($0.01) | $-0.00 | ($0.01) | ($12.28) | ($3.35) | ($3.28) | ($0.18) | ($3.49) | ($13.96) | |
| Diluted Earnings (Loss) Per Share | $-0.00 | $-0.00 | ($0.01) | $-0.00 | ($0.01) | ($12.28) | ($3.35) | ($3.28) | ($0.18) | ($3.49) | ($13.96) | |
| Weighted Average Shares Outstanding, Diluted | 145.5m | 129.6m | 31.5m | 57.2m | 127.8m | $63.7m | $65.9m | $70.6m | $75.5m | — | — | |
| Basic Average Shares | $145.5m | $129.6m | $31.5m | $57.2m | $127.8m | $63.7m | $65.9m | $70.6m | $75.5m | — | $89.0m | |
| Diluted Average Shares | $145.5m | $129.6m | $31.5m | $57.2m | $127.8m | $63.7m | $65.9m | $70.6m | $75.5m | — | $89.0m | |
| Additional Financial Items | ||||||||||||
| Depreciation Right of Use Assets | — | — | — | — | — | — | — | $1.6m | $1.5m | — | $47.0m | |
| Profit Loss Attributable To Noncontrolling Interests | — | — | — | — | — | — | — | ($75k) | ($34k) | — | — | |
| Profit Loss Attributable To Owners Of Parent | — | — | — | — | — | — | — | ($925.6m) | ($55.5m) | — | — | |
| Profit Loss Before Tax | — | — | — | — | — | — | — | ($932.9m) | ($54.1m) | — | — | |
| Share of profit/(loss) of a joint venture | — | — | — | — | — | — | ($278k) | $1.1m | ($281k) | $314k | — | |
| LOSS BEFORE TAX | ($887.2m) | ($932.9m) | ($395.3m) | ($1.2b) | ||||||||
| LOSS FOR THE YEAR | ($155k) | ($782k) | ($283k) | ($1.5m) | ($882.9m) | ($925.7m) | ($405.7m) | ($1.2b) | ||||
| Ordinary equity holders of the Company | — | ($155k) | ($782k) | ($283k) | ($1.5m) | — | ($882.9m) | ($925.6m) | ($405.4m) | ($1.2b) | — | |
| Non-controlling interests | — | — | — | — | — | — | — | ($75k) | ($247k) | ($218k) | — | |
| Professional Fees | — | $44k | $129k | $45k | $37k | — | — | — | — | — | — | |
| Extraordinary Items | ($100k) | ($140k) | — | — | — | — | — | — | — | — | — | |
| Profit or Loss | ($100k) | ($169k) | ($184k) | ($283k) | — | — | — | — | — | — | — | |
| Consulting fees | — | — | — | $0 | $269k | — | — | — | — | — | — | |
| Consulting fees paid with stock | — | — | — | $0 | $118k | — | — | — | — | — | — | |
| Loss due to revaluation of investment | — | — | — | $0 | ($9k) | — | — | — | — | — | — | |
| Loss due to impairment of mineral rights | — | — | — | $0 | ($4k) | — | — | — | — | — | — | |
| Loss on conversion of debt | — | — | — | $0 | ($506k) | — | — | — | — | — | — | |
| Foreign exchange (loss) | — | — | — | ($2k) | ($6k) | — | — | — | — | — | — | |
| Comprehensive (loss) | — | — | — | ($285k) | ($1.5m) | — | — | — | — | — | — | |
| Stock-Based Compensation (Equity) | — | — | $32k | $7k | — | — | — | — | — | — | — | |
| Income from Continuing Operations | — | — | ($163k) | ($254k) | — | — | — | — | — | — | — | |
| Diluted EPS | — | — | — | — | — | ($12.28) | ($13.40) | ($13.12) | ($5.36) | — | ($13.96) | |
| Diluted NI Availto Com Stockholders | — | ($155k) | ($782k) | ($283k) | ($1.5m) | — | ($882.9m) | ($925.6m) | ($405.4m) | ($1.2b) | ($1.2b) | |
| Earnings From Equity Interest | — | — | — | — | — | — | ($278k) | $1.1m | ($281k) | $314k | $314k | |
| Minority Interests | — | — | — | — | — | — | $0 | $75k | $247k | $218k | $218k | |
| Normalized EBITDA | — | — | — | — | — | — | ($780.5m) | ($747.4m) | ($243.4m) | ($1.1b) | ($1.1b) | |
| Normalized Income | — | — | — | — | — | — | ($891.9m) | ($929.4m) | ($409.8m) | ($1.2b) | ($1.2b) | |
| Other Gand A | — | $10k | $5 | $8k | $29k | — | $170.6m | $181.1m | $187.1m | $246.3m | — | |
| Other Special Charges | — | — | — | — | — | $34k | ($2.1m) | ($4k) | — | — | — | |
| Reconciled Depreciation | — | — | — | — | — | — | $62.9m | $93.2m | $93.2m | $86.5m | $47.0m | |
| Selling General And Administration | — | — | — | — | — | — | $328.0m | $376.5m | $383.1m | $599.9m | — | |
| Special Income Charges | — | — | — | — | — | — | $2.1m | $4k | ($50k) | ($18k) | ($18k) | |
| Tax Effect Of Unusual Items | — | — | — | — | — | — | $45k | $29k | $1.5m | ($2.8m) | ($2.8m) | |
| Tax Provision | — | — | — | — | — | — | ($4.2m) | ($7.2m) | $10.4m | $6.9m | $6.9m | |
| Tax Rate For Calcs | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Administrative Expense | — | — | — | — | — | — | — | $181.1m | $25.6m | — | — | |
| Donations And Subsidies Expense | — | — | — | — | — | — | — | $4.0m | $866k | — | — | |
| Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used | — | — | — | — | — | — | — | $181k | $33k | — | — | |
| Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities | — | — | — | — | — | — | — | $181k | $33k | — | — | |
| Finance Costs | — | — | — | — | — | — | ($52.8m) | $96.1m | $8.8m | ($54.1m) | — | |
| Postemployment Benefit Expense Defined Contribution Plans | — | — | — | — | — | — | — | $30.7m | $4.7m | — | — | |
| Selling Expense | — | — | — | — | — | — | — | $195.4m | $26.9m | — | — | |
| Selling and distribution expenses | — | — | — | — | — | — | ($157.4m) | ($195.4m) | ($196.0m) | ($353.6m) | — | |
| Other Operating Expense | — | $0 | $2k | $195k | $18k | — | — | — | — | — | — | |
| Occupancy and Rent Expense | — | — | — | $0 | $548 | — | — | — | — | — | — | |
| Stock-Based Compensation Expense | — | $16k | $631k | $7k | $0 | — | — | — | — | — | — | |
| Operating Expense | — | — | — | — | — | — | $1.0b | $1.1b | $1.3b | $1.7b | $1.7b | |
| Total Unusual Items | — | — | — | — | — | — | $9.0m | $3.7m | $5.8m | ($11.3m) | ($11.3m) | |
| Total Expenses | — | — | — | — | — | — | $1.1b | $1.1b | $1.4b | $1.8b | $1.8b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.